KMC hospital seeks DCGI permission to begin plasma therapy
Mangaluru - KMC Hospital in Manipal has sought the permission from Drug Controller General of India (DCGI) to start plasma therapy for the treatment of severely-ill Covid-19 patients.
Once the permission is given, the plasma therapy will be started at the hospital to treat the patients.
Read Also: Plasma therapy trial did not show benefit in decreasing Coronavirus mortality risk: AIIMS
Convalescent Plasma Therapy involves collecting convalescent plasma or the liquid part of the blood from a blood donor. The idea behind the treatment is to extract blood bearing Covid-19 antibodies from patients who have survived the infection and provide them to those who are infected. It helps in transferring antibody to the infected patients, said Dr Shashikiran Umakanth of Dr T M Pai Hospital in Udupi.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.